We are very excited to introduce you to Andy Lewis, Yahya Choonara, Dimitrios Lamprou, Raju Vivek, Lingling Shen and Hitesh Kulhar as part of the inaugural Advisory Board for RSC Pharmaceutics!
Dr Andy Lewis is Chief Scientific Officer, Quotient Sciences, UK. He has over 20 years experience working in the pharmaceutical and biotech industry focussed on advanced drug delivery technologies particularly protein and peptide drug delivery, solubility enhancement and controlled release.
“I look forward to joining the Advisory Board for the new RSC Pharmaceutics journal and supporting its development into a world leading journal for pharmaceutical scientists. As it’s a Gold Open Access journal researchers publishing in it can be confident of a wide dissemination of their work to help build their reputation.”- Dr Andy Lewis
Professor Yahya Choonara is part of Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology in the School of Therapeutic Science, Faculty of Health Sciences, University of the Witwatersrand located in Johannesburg, South Africa.
“I am pleased to serve on the Advisory Board of RSC Pharmaceutics which is a top-tier platform for advancing the frontier of pharmaceutical innovation and communicating the latest science in drug delivery, formulation, and discovery. The journal provides a vibrant and inclusive space for scientists from diverse backgrounds to share ideas, challenge assumptions, and shape the future of pharmaceutical science for the betterment of global health” – Professor Yahya. Choonara
Professor Dimitrios Lamprou is a Full Professor (Chair) of Biofabrication and Advanced Manufacturing and Director at MSc Industrial Pharmaceutics at Queen’s University Belfast School of Pharmacy. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS), Committee Member of the British Standards Institute (BSI) AMT/8 for Additive Manufacturing, and Visiting Professor in a number of international Institutions
“I am very familiar with the Royal Society of Chemistry(RSC) journals and values, is an honour to be part of this family. With this appointment, I will be able to further support the journal, weed out low-quality contributions, guarantee the calibre of the articles that are published, and, at the same time, boost the topic. Pharmaceutics is an important field and this new journal will bring research more visual to researchers in the field by bringing fundamental and advanced research to them, supporting the development of advanced Drug Delivery Systems (DDSs)”.– Professor Dimitrios Lamprou
Dr. Raju Vivek is an Assistant Professor of Bharathiar University located in India.
“I am thrilled to be a part of the advisory board for RSC Pharmaceutics, a platform that showcases cutting-edge research in the field of pharmaceutics. As a member of the board, I am excited to contribute to the publication of innovative studies that will shape the future of pharmaceutical research. RSC Pharmaceutics is dedicated to highlighting novel discoveries and advancements in pharmaceutics, with a focus on high-potential therapeutics research. I look forward to working with the team to establish the journal as a leading voice in the field and to fostering the sharing of groundbreaking ideas and findings”– Dr. Raju Vivek
Dr Lingling Shen, is an Associate Director of Data Science and Discovery Sciences at Novartis Biomedical Research.
“RCS Pharmaceutics aims to be the ideal platform for all researchers including those from the industry, to share their work, even with confidentiality constraints. I’m excited about the journal’s supportive and efficient publishing process and hopeful it will grow to become a leading publication in the field.” – Dr Lingling Shen
Dr. Hitesh Kulhar is part of the School of Nano Sciences at the Central University of Gujarat located in Gandhinagar, India
“It is a privilege to be a part of the Royal Society of Chemistry (RSC) which is one of the oldest research and scientific communities and the subject of Pharmaceutics is close to my heart. So, I feel honored and delighted to be part of RSC Pharmaceutics.
RSC Pharmaceutics is a unique forum to provide communication between pharmaceutical formulation researchers, scientists and industries. It will showcase the research advances made in the areas of drug delivery, drug targeting and precision medicines.” – Dr. Hitesh Kulhar
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.